SWOT Analysis for Ajanta Pharma Ltd.

Consistent Highest Return Stocks over Five Years
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Dividend yield greater than sector dividend yield
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Volume Shockers

MACD Crossover Below Signal Line
Promoters increased pledged shares QoQ
Falling Comet (DVM)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Weak Momentum: Price below Short, Medium and Long Term Averages
High volume, top losers
RSI indicating price weakness
MACD crossed below signal line previous end of day
High promoter stock pledges
Highest increase in pledges by promoters
Top Losers
High Volume, Top Losers
Stocks Underperforming their Industry Price Change in the Quarter

Broker price or reco upgrades in last month
Brokers upgraded recommendation or target price in the past three months
Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Broker price or reco upgrades in last month